Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
908 INR | +2.42% | +6.81% | -0.23% |
02:03pm | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
Apr. 03 | Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.23% | 1.47B | |
+38.22% | 705B | |
+32.82% | 583B | |
-3.75% | 364B | |
+19.80% | 332B | |
+4.89% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.83% | 169B |
- Stock Market
- Equities
- ERIS Stock
- News Eris Lifesciences Limited
- Transcript : Eris Lifesciences Limited, Q2 2023 Earnings Call, Oct 20, 2022